Au KP, Chok KSH. Surgical cystogastrostomy: Is it still worthwhile? World J Gastroenterol 2024; 30(17): 2298-2301 [PMID: 38813046 DOI: 10.3748/wjg.v30.i17.2298]
Corresponding Author of This Article
Kenneth Siu Ho Chok, FACS, FRCS (Ed), MBBS, MD, MS, Professor, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong 999077, China. kennethchok@gmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. May 7, 2024; 30(17): 2298-2301 Published online May 7, 2024. doi: 10.3748/wjg.v30.i17.2298
Surgical cystogastrostomy: Is it still worthwhile?
Kin Pan Au, Kenneth Siu Ho Chok
Kin Pan Au, Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong 999077, China
Kenneth Siu Ho Chok, Department of Surgery, The Chinese University of Hong Kong, Hong Kong 999077, China
Author contributions: Chok KSH initiated the idea of writing up the Editorial; Au KP and Chok KSH contributed to the manuscript writing equally; Chok KSH critically revised the final paper.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kenneth Siu Ho Chok, FACS, FRCS (Ed), MBBS, MD, MS, Professor, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong 999077, China. kennethchok@gmail.com
Received: February 12, 2024 Revised: March 10, 2024 Accepted: April 15, 2024 Published online: May 7, 2024 Processing time: 82 Days and 20.7 Hours
Abstract
The article by Ker et al explores the treatment of peripancreatic fluid collection (PFC). The use of percutaneous drainage, endoscopy, and surgery for managing PFC are discussed. Percutaneous drainage is noted for its low risk profile, while endoscopic cystogastrostomy is more effective due to the wider orifice of the metallic stent. Surgical cystogastrostomy is a definitive treatment with a reduced need for reintervention, especially for cases with extensive collections and significant necrosis. The choice of treatment modality should be tailored to individual patient characteristics and disease factors, considering the expertise available.
Core Tip: Treatment options of peripancreatic fluid collection (PFC) include percutaneous drainage, endoscopy, and surgery. Percutaneous drainage is noted for its low risk profile, while endoscopic cystogastrostomy is more effective due to the wider orifice of the metallic stent. Surgical cystogastrostomy is a definitive treatment with a reduced need for reintervention, especially for cases with extensive collections and significant necrosis. The choice of treatment modality should be tailored to individual patient characteristics and disease factors, considering the expertise available.
